What’s the difference in the 3 G - L- P options? 🔹 Sema (O z e m p, We govy , Rybelsus) Targets: GLP-1 only What it does: ▫️ Lowers blood sugar ▫️ Slows digestion ▫️ Strong appetite suppressant Used for: Type 2 diabetes, weight loss 🔹 Tirzep (Mounjar0, Zepbound) Targets: GLP-1 + GIP (dual agonist) What it does: ▫️ Similar effects as semaglutide, but enhanced ▫️ More potent for blood sugar control and weight loss Used for: Type 2 diabetes, weight loss 🔹 Reta (phase 3 clinical trials) Targets: GLP-1 + GIP + glucagon (triple agonist) What it does: ▫️ Most powerful weight loss effects so far 28% fat loss in recent studies ▫️ Boosts metabolism via glucagon pathway ▫️restores lean muscle while adding a fat burning component

Happy Thursday! The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023. Their reasoning? Insufficient evidence on whether it causes harm to humans. Meanwhile, hundreds of thousands of people have used BPC-157, including many of you reading this right now. And most of you walked away with zero adverse events and a healed injury. But as of now, we have no documented way to verify the safety and efficacy of some of the most common and effective peptides. Well, hopefully that’s about to change. The Project I've been working on something behind the scenes with a team of heavy hitters that I'm finally ready to share with you. It's called the Peptide Safety Initiative. The FDA says there isn't enough human safety data on BPC-157 to justify allowing compounding pharmacies to produce it. The published clinical data are razor-thin. One small pilot study. A couple of retrospective case reviews. No large-scale human trials. But what does the FDA not have access to? Your experience. The real-world experience of the thousands of people who have used BPC-157 for gut healing, tendon repair, joint recovery, post-surgical rehab, and everything in between. That gap between what regulators see on paper and what our community has experienced firsthand is the entire problem. So we built a tool to close that gap. The Peptide Safety Initiative We created a structured reporting platform where you can document your personal experience with BPC-157. The data gets aggregated and de-identified. Then it goes directly to the doctors and researchers working with the FDA on peptide reclassification. This is a real-world evidence collection effort modeled after the kind of data regulatory bodies actually take seriously. There is a commission currently reviewing the Category 2 designation for several peptides. The doctors on that commission need volume. They need to show the FDA that real humans have used this compound, here's what happened, and here's the safety profile across a large population.

Sleep is actually four different problems. Most people treat it like one thing, throw melatonin at it, and wonder why they still wake up wrecked. The first is low growth hormone during sleep. Your body releases most of its GH in the first couple hours of deep sleep, and if that pulse isn't firing right, you're not actually recovering. Ipamorelin works through ghrelin receptor signaling to directly promote slow-wave sleep — a 2002 study in the American Journal of Physiology confirmed this in humans. Second is the racing mind. Brain won't stop, you just can't fall asleep. DSIP (delta sleep-inducing peptide) is what's being researched here. Human trials including a double-blind study in chronic insomniacs showed better sleep efficiency and faster sleep onset. Third is "tired but wired." Completely depleted but can't settle. This usually points to mitochondrial dysfunction. SS-31 targets cardiolipin in the inner mitochondrial membrane — the FDA cleared it for Barth syndrome in 2025 and the fatigue data from those trials was solid. Fourth is broken circadian rhythm. You fall asleep fine but wake up at 3am. Epitalon works on the pineal gland to drive melatonin production through the enzyme pathway. Brunel University London confirmed the telomerase findings independently in 2025. Here's what I see people getting wrong: they buy all four and run them together. You won't know what worked. Most people have one or two dominant patterns. Figure out which one fits you first. Which of the four patterns sounds like you? Drop it below — this community has people who've worked through all of them. *This is Not medical advice, Not your doctor. Please also Do your own research.

Guess whose package came in! Excited💃🤭🫶